GlaxoSmithKline Pakistan Limited's latest marketcap:
As of 07/19/2026, GlaxoSmithKline Pakistan Limited's market capitalization has reached $410.42 M. According to our data, GlaxoSmithKline Pakistan Limited is the 16094th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 410.42 M |
| Revenue (ttm) | 242.61 M |
| Net Income (ttm) | 37.86 M |
| Shares Out | 318.47 M |
| EPS (ttm) | 0.12 |
| Forward PE | 9.95 |
| Ex-Dividend Date | 04/24/2026 |
| Earnings Date | 08/24/2026 |
GlaxoSmithKline Pakistan Limited's yearly market capitalization.
| Date | Market Cap(rs) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | rs113.93 B | $410.42 M | -2.88% | 16094 |
| 12/31/2025 | rs124.13 B | $442.46 M | -1.8% | 14549 |
| 12/31/2024 | rs126.4 B | $447.47 M | 378.26% | 13691 |
| 12/29/2023 | rs26.43 B | $92.5 M | -5.45% | 23595 |
| 12/30/2022 | rs27.95 B | $122.15 M | -35.7% | 20995 |
| 12/31/2021 | rs43.47 B | $244.32 M | -28.84% | 17676 |
| 12/31/2020 | rs61.09 B | $378.16 M | 19.47% | 13218 |
| 12/31/2019 | rs51.14 B | $327.78 M | 42.5% | 12271 |
| 12/31/2018 | rs35.88 B | $256.94 M | -32.88% | 12674 |
| 12/29/2017 | rs53.46 B | $481.18 M | -27.64% | 10611 |
Company Profile
About GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited is a leading biopharmaceutical company operating in Pakistan, specializing in a diverse range of therapeutic areas.
Core Business Areas
- Anti-infective treatments
- Dermatology solutions
- Respiratory care products
- Immunology therapies
- Oncology treatments
- Infectious diseases management
- HIV medications
- Vaccines for disease prevention
Popular Brands
The company markets its products under well-known brand names including:
- Augmentin
- Velosef
- Amoxil
- Dermovate
- Clobevate
- Betnovate
- Calpol
- Cutivate
Company Overview
Founded in 2001 and headquartered in Karachi, Pakistan, the company operates as a subsidiary of global pharmaceutical leader GSK plc. In addition to serving the domestic market, GlaxoSmithKline Pakistan Limited exports its pharmaceutical products internationally.
Frequently Asked Questions
-
What is GlaxoSmithKline Pakistan Limited's (PSX-GLAXO) current market cap?As of 07/19/2026, GlaxoSmithKline Pakistan Limited (including the parent company, if applicable) has an estimated market capitalization of $410.42 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GlaxoSmithKline Pakistan Limited (PSX-GLAXO) rank globally by market cap?GlaxoSmithKline Pakistan Limited global market capitalization ranking is approximately 16094 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.